We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Did you know? You can double click on a word to look it up on TermGallery.
Meanings of orally bioavailable in English
We have no meanings for "orally bioavailable" in our records yet.
Usage of orally bioavailable in English
1
Olinciguat was orallybioavailable and predominantly cleared by the liver in rats.
2
One reason we switched was because the Glaxo compound was not orallybioavailable.
3
E913 and its analogs are acid-resistant and orallybioavailable in rodents.
4
The desired outcome of the study was to identify an orallybioavailable TF-VIIa inhibitor.
5
Little progress has been reported in developing longer acting or orallybioavailable fusion inhibitors.
6
Conclusions and implications: Methnaridine is an orallybioavailable, fast-acting and long-lasting agent with excellent antimalarial properties.
7
CHR-2797 is orallybioavailable and currently undergoing phase II clinical investigation in the treatment of myeloid leukemia.
8
Therefore, a safe and orallybioavailable intervention for therapy of osteolytic bone resorption is still a clinically unmet need.
9
Thus, apixaban is an orallybioavailable inhibitor of factor Xa with elimination pathways that include metabolism and renal excretion.
10
VX-787 is a first in class, orallybioavailable compound that offers unparalleled potential for the treatment of pandemic and seasonal influenza.
11
We previously described a regulatory system that enables transcription of a target gene to be controlled by rapamycin, an orallybioavailable drug.
12
IQN17 and these D-peptide inhibitors are likely to be useful for development and identification of a new class of orallybioavailable anti-HIV drugs.
13
Context: MK-5442 is an orallybioavailable calcium-sensing receptor antagonist that is hypothesized to stimulate bone formation by stimulating endogenous secretion of a pulse of PTH.
14
Compound 3 has provided a significant stepping stone towards the discovery of the orallybioavailable B 2 antagonist PHA-022121, currently in phase 1 clinical development.
15
In an effort to obviate these challenges, we set out to develop an orallybioavailable, selective Na V 1.7 inhibitor, lacking these acidic functional groups.